Journals / Adli Tıp Dergisi / 1988 / Cilt: 4 Sayı: 3-4

Studies on in vitro Hemolytic Effect of Morphine Sulphate

S. William(Department of Biochemistry, University of Madras, Guindy Campus, Madras)
Pages
111–116
Publication Date
1988-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Erythrocytes preincubated with glucose and A TP proteet the celis against morphine induced lysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In vitro studies on hemolytic effect of morphine sulphate (MS) has been carried out on rat and human erythrocytes and are found to be susceptible to hemolysis.
📊
Key Findings & Data:The depletion of glutathione and the increase in lipid peroxidation may be responsible for the disintegration of erythrocyte membrane.
💡
Conclusion & Impact:Erythrocytes preincubated with glucose and A TP proteet the celis against morphine induced lysis.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Morphine sulphate · Glucose and ATP · Hemolytic effect

Abstract

In vitro studies on hemolytic effect of morphine sulphate (MS) has been carried out on rat and human erythrocytes and are found to be susceptible to hemolysis. Comparatively human erythrocytes are most sensitive to hemolysis by MS. The degree of hemolysis is found to be dose dependenl. The depletion of glutathione and the increase in lipid peroxidation may be responsible for the disintegration of erythrocyte membrane. Erythrocytes preincubated with glucose and A TP proteet the celis against morphine induced lysis.

🔖

Cite This Article

William, S. (1988). Studies on in vitro Hemolytic Effect of Morphine Sulphate. Adli Tıp Dergisi, Cilt: 4 Sayı: 3-4, 111–116. https://ajindex.com/articles/1353003

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. JJ-H. Jaffe, W.R.:\fanin (1980) in The Pharmacoiogica/ Basis of Therapeutics, 2nd cdn (A.G. Gilman, LS. Goodman, A.Gilman, ed.) pp.494-S20, ~v1ucmiııalı Publi;;huıg Co.• New York.
  2. Feldbcrg, W., Shaligram, S.V. (1972) B,. 1. Phamuıcol., 46, 602-618.
  3. Trotta, R.J., Sullivan, S.G., Stern, A., (1983) Biochem. f.,212, 759-773.
  4. Fiske, C.H., Suhbarow, Y. (1925) IBiol. Chem, 66, 375-38 L
  5. Parekh, A.C., Jung, D.H. (19'10) AnaL. Chem, 42, 1423-1436.
  6. Warren, L (1959) J. Bio/. C/um, 234, 234-242.
  7. Ohakawa, H., Obı.sni, N., Yagi, M. (1979) Anal. Biochem.,9S, 351-372.
  8. Moron. M.S., Depterre,.ı.W., Manneröik, (1979) Rıochim. Biophys. Acla,582, 67-74.
  9. Drabkin, D.L, Austin, J.H. (1935) J. Biol. Chem., 112, 51-62.
  10. Nci!, A.L, Charles. R.Z. (1988) Biochim. Biophys. ACla, 964, 96-104. J ı Brody, A.R., Gerwyn, G., Lila. H. (1983) Lab. ["vest., 49, 468-474.
  11. Cooper, R.A.~ Durochcr. J.R., Le.lic, MJ!. (1977) J. Clin. Chem., 60. ı 15-121.
  12. Plaa. G.L, Wiıselıi, ıı. (1976) Ann. Rev. Pharmacol. Toxicol., 16, 125-141.
  13. JJ-H. Jaffe, W.R.:\fanin (1980) in The Pharmacoiogica/ Basis of Therapeutics, 2nd cdn (A.G. Gilman, LS. Goodman, A.Gilman, ed.) pp.494-S20, ~v1ucmiııalı Publi;;huıg Co.• New York.
  14. Moron. M.S., Depterre,.ı.W., Manneröik, (1979) Rıochim. Biophys. Acla,582, 67-74.